Full name
ROYALMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.21.Z - General medical practice activities
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
86.22.Z - Specialist medical practice activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
2020 | 2021 | ||
---|---|---|---|
M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | 0,1 | -87,7 |
Gross profit (loss) | 0,5 | 0,4 | -15,1 |
EBITDA | 0,7 | 0,5 | -23,2 |
Short time liabilities | 0,4 | 0,4 | 3,1 |
Other operating costs | 0 | 0 | -100 |
Equity capital | 1,5 | 1,9 | 27,1 |
Operating profit (EBIT) | 0,5 | 0,4 | -22 |
Assets | 2,3 | 2,5 | 8,7 |
Net profit (loss) | 0,4 | 0,4 | 3 |
Cash | 0,5 | 0,6 | 13,7 |
Net income from sale | 5,6 | 4,1 | -27,3 |
Liabilities and provisions for liabilities | 0,8 | 0,6 | -24,4 |
Working assets | 1,3 | 1,6 | 22,3 |
Other income costs | 0 | 0,3 | 7251 |
Depreciation | 0,2 | 0,2 | -25,8 |
% | % | p.p. | |
Profitability of capital | 26,3 | 21,3 | -5 |
Equity capital to total assets | 64,1 | 75 | 10,9 |
Gross profit margin | 8,6 | 10,1 | 1,5 |
EBITDA Margin | 12,3 | 13 | 0,7 |
Days | Days | Days | |
Short term commitment turnover cycle | 26 | 37 | 11 |
Current financial liquidity indicator | 3.3043053150177 | 3.919525146484375 | 0,6 |
Net dept to EBITDA | -0.17238740622997284 | -1.054541826248169 | -0,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane